Social and behavioral determinants of MOUD utilization and opioid overdose

MOUD 使用和阿片类药物过量的社会和行为决定因素

基本信息

  • 批准号:
    10664099
  • 负责人:
  • 金额:
    $ 75.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

Social and behavioral determinants of MOUD utilization and opioid overdose In the US, over 192 people die each day due to opioid overdose (OOD), the leading cause of accidental death among adults. Veterans are especially vulnerable to OOD, experiencing rates double those of non-Veterans, due to their higher prevalence of opioid use disorder (OUD). Medication treatment for OUD (MOUD) is the gold standard treatment for opioid use disorder (OUD). However, in the Veterans Health Administration of the Department of Veterans Affairs (VA) and non-VA hospitals, access to MOUD care is lacking. Compounding poor access, many patients who receive buprenorphine discontinue within 1 year, an indicator of suboptimal treatment retention. Social determinants of health are the conditions in which people are born, live, work, and age. Adverse social determinants of health include job insecurity, housing insecurity, financial insecurity, food insecurity, as well as legal, social/familial, transportation, and violence problems. Together with adverse behavioral health factors such as substance use and mental health disorders (e.g., major depression), adverse social and behavioral determinants of health (SBDH) are associated with poorer health, and concurrent adverse SBDH can have compounding negative health consequences. The overarching goal of this proposal is to understand SBDH, biological variables, clinical settings and clinical factors that impact MOUD access and outcomes and to develop predictive models for MOUD outcomes.
MOUD使用和阿片类药物过量的社会和行为决定因素 在美国,每天有超过192人死于阿片类药物过量(OOD),这是意外死亡的主要原因 在成年人中。退伍军人特别容易受到OOD的影响,其发病率是非退伍军人的两倍, 因为他们的阿片类药物使用障碍(OUD)患病率较高。药物治疗OUD(MOUD)是黄金 阿片类药物使用障碍(OUD)的标准治疗。然而,在退伍军人健康管理局, 退伍军人事务部(VA)和非VA医院,缺乏获得MOUD护理的机会。配混 难以获得,许多接受丁丙诺啡的患者在1年内停药,这是一个次优指标, 治疗保留。 健康的社会决定因素是人们出生、生活、工作和年龄的条件。不良社会 健康的决定因素包括工作无保障、住房无保障、财政无保障、粮食无保障,以及 法律的、社会/家庭、交通和暴力问题。加上不良的行为健康因素 例如物质使用和精神健康障碍(例如,抑郁症),不良的社会和行为 健康决定因素(SBDH)与健康状况较差有关,同时发生的不良SBDH可能 加重了对健康的负面影响。本提案的首要目标是了解SBDH, 生物学变量、临床环境和影响MOUD访问和结局的临床因素, 开发MOUD结果的预测模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wenjun Li其他文献

Wenjun Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wenjun Li', 18)}}的其他基金

Neighborhood Risk Factors for Falls in the Elderly
老年人跌倒的社区危险因素
  • 批准号:
    10396681
  • 财政年份:
    2020
  • 资助金额:
    $ 75.3万
  • 项目类别:
Neighborhood Risk Factors for Falls in the Elderly
老年人跌倒的社区危险因素
  • 批准号:
    10625284
  • 财政年份:
    2020
  • 资助金额:
    $ 75.3万
  • 项目类别:
Neighborhood Risk Factors for Falls in the Elderly
老年人跌倒的社区危险因素
  • 批准号:
    10342708
  • 财政年份:
    2020
  • 资助金额:
    $ 75.3万
  • 项目类别:
Microsurgery Core
显微外科核心
  • 批准号:
    10625535
  • 财政年份:
    2015
  • 资助金额:
    $ 75.3万
  • 项目类别:
Microsurgery Core
显微外科核心
  • 批准号:
    10024443
  • 财政年份:
    2015
  • 资助金额:
    $ 75.3万
  • 项目类别:
Microsurgery Core
显微外科核心
  • 批准号:
    10197015
  • 财政年份:
    2015
  • 资助金额:
    $ 75.3万
  • 项目类别:
Microsurgery Core
显微外科核心
  • 批准号:
    10619066
  • 财政年份:
    2015
  • 资助金额:
    $ 75.3万
  • 项目类别:
Health Care Reform and Disparities in the Care and Outcomes of Trauma Patients
医疗保健改革以及创伤患者护理和结果的差异
  • 批准号:
    8449532
  • 财政年份:
    2011
  • 资助金额:
    $ 75.3万
  • 项目类别:
Health Care Reform and Disparities in the Care and Outcomes of Trauma Patients
医疗保健改革以及创伤患者护理和结果的差异
  • 批准号:
    8154107
  • 财政年份:
    2011
  • 资助金额:
    $ 75.3万
  • 项目类别:
Health Care Reform and Disparities in the Care and Outcomes of Trauma Patients
医疗保健改革以及创伤患者护理和结果的差异
  • 批准号:
    8278550
  • 财政年份:
    2011
  • 资助金额:
    $ 75.3万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了